Yes — and it is one of the most efficient routes there is, because blood goes straight into the bloodstream. CDC estimates 63 HIV transmissions per 10,000 needle-sharing exposures (95% CI 41–92)[1][2]. It is also highly preventable: new sterile equipment every time, syringe services programs, PrEP, and regular HIV and hepatitis C testing all work[3].
What the risk actually is
CDC's per-act risk table puts needle-sharing during injection drug use at 63 per 10,000 exposures. For comparison, on the same table: receptive anal intercourse is 138, a percutaneous needle-stick is 23, and blood transfusion is 9,250[1]. The systematic review underlying that table gives the needle-sharing estimate as 63 per 10,000 exposures with a 95% confidence interval of 41 to 92[2].
Two caveats keep that number honest. First, single-act numbers understate lived risk: CDC notes that “risks do add up over time. Even relatively small risks can add up over time and lead to a high lifetime risk of getting HIV”[1]. Second, “sharing needles” is broader than most people assume — CDC's framing is “sharing needles, syringes, or other drug injection equipment — for example, cookers”[3]. Cookers, cotton, water, and ties all carry blood.
One precision point that gets muddled: Undetectable = Untransmittable is established for sexual transmission. For shared injection equipment, the size of the risk reduction from an undetectable viral load has not been established, so U=U should not be treated as protection when equipment is shared[1].
Syringe services programs work — this is settled evidence
CDC frames this as a structural problem, not a moral one: injection drug use “created prevention challenges and placed new populations at risk for HIV… This highlights the need for strengthened HIV prevention efforts for PWID, such as expanding coverage and support for comprehensive syringe services programs (SSPs)”[3]. For scale: adults and adolescents who inject drugs accounted for 10% (3,864) of the 37,968 new HIV diagnoses in the U.S. and dependent areas in 2018[3].
The evidence on SSPs is not close. CDC states that SSPs are associated with an estimated 50% reduction in HIV and hepatitis C infections, and that “transmission is reduced by over two-thirds when combined with medications that treat opioid dependence”[4]. Nearly 30 years of research finds comprehensive SSPs “are safe, effective, and cost-saving, do not increase illegal drug use or crime, and play an important role in reducing the transmission of viral hepatitis, HIV and other infections”[4].
They are also a way in, not a way around treatment: new SSP participants are “five times more likely to enter drug treatment” and “three times more likely to stop using drugs than those who don't use the program”[4]. And they protect everyone — including first responders and sanitation workers — through safe needle disposal, naloxone distribution, and overdose-response training[4].
PrEP plus syringe services: use both
PrEP is not just for sexual exposure. CDC reports that “when taking PrEP consistently, the risk of acquiring HIV is reduced by an estimated 74–84% among PWID” — figures from the Bangkok Tenofovir Study, which found 74% protection with near-daily use and roughly 84% at 97.5% adherence[1]. Layering PrEP on top of new equipment every time closes the gaps that any single tool leaves open.
If an exposure has already happened, PEP — post-exposure prophylaxis — is available, and timing is everything: HIV medicine for PEP “should be taken within 3 days (72 hours) after a possible exposure”[5]. Sooner is better; an emergency department, urgent care, or sexual health clinic can start it.
The fentanyl and xylazine reality
The current supply changes the math. Xylazine “is especially dangerous when combined with opioids like fentanyl,” is usually injected, and can cause “wounds that can become infected,” severe withdrawal, and death — and CDC notes plainly that “people who use illegal drugs may not be aware of the presence of xylazine”[6]. Nobody consents to what they cannot test for.
Wound care is HIV prevention here, because open wounds and repeated injection into damaged tissue raise the stakes of every shared piece of equipment. CDC: “Skin wounds may become infected and worsen quickly. When treated early, wounds can be managed with basic wound care techniques. If left untreated, wounds can lead to amputation or become life threatening.” Infection risk drops with “sterile injection equipment, rotating injection sites, allowing skin and veins time to heal… and taking drugs in other ways besides injection”[6].
Practical version: use a new sterile syringe and new cooker, cotton, water, and tie for every injection; never share any of it; carry naloxone; and get tested for HIV and hepatitis C regularly, because both are treatable and hepatitis C is curable.
Florida: the IDEA Act and the IDEA Exchange
Syringe services are legal statewide in Florida. “On June 27, 2019, Gov. Ron DeSantis signed into law the Infectious Disease Elimination Act (IDEA) that allows county commissions to authorize sterile needle and syringe exchange programs for people who inject drugs”[7]. Florida DOH's own rationale: “studies show that exchange programs significantly reduce overdose-related deaths and prevent diseases like HIV and hepatitis B and C — they also reduce the risks of community outbreaks”[7].
The law's constraints are unusual and worth knowing before you go. Programs cannot use state, county, or municipal funds and must run on grants and private donations; participants' personal identifying information “cannot be collected or used for any purpose”[7]. Each program requires a county ordinance and a letter of agreement with Florida DOH under s. 381.0038 F.S., must partner with the county health department, and must be operated by a licensed hospital, licensed health care clinic, accredited Florida medical school, licensed addiction receiving facility, or a 501(c)(3) HIV/AIDS service organization. IDEA also imposes a strict one-to-one exchange — one new syringe for each one returned — plus education on HIV and viral hepatitis, on-site counseling or referrals for substance use treatment, HIV and viral hepatitis screening or referrals, and naloxone kits or referrals, with annual reports due to county commissioners and DOH by August 1[8].
Miami's IDEA Exchange came first: it “opened its doors on December 1, 2016, on World AIDS Day, as the first pilot Syringe Services Program in Florida” and Florida's first legal program[9]. It does far more than hand out syringes — substance use disorder treatment, HIV prevention, testing and treatment, hepatitis C testing and treatment, wound care, medication management, appointment reminders, and peer navigation for housing and insurance[9].
Why this matters locally: in 2023, 174 adults (3% of Florida's adult HIV diagnoses) had HIV attributed to injection drug use, with another 69 attributed to both male-to-male sexual contact and injection drug use. Of the 11,972 people living with HIV in Florida who inject drugs, 75% were in care, 69% retained, and 62% virally suppressed — versus 70% statewide[10]. That gap is a service-access problem, not a character problem.
Related questions
What is the actual risk of getting HIV from sharing a needle?
CDC estimates 63 HIV transmissions per 10,000 needle-sharing exposures, with a 95% confidence interval of 41 to 92. That makes it one of the most efficient documented routes, and CDC also notes that small per-act risks add up over time into a high lifetime risk.
Does sharing cookers, cotton, or water carry HIV risk too?
Yes. CDC's guidance covers "sharing needles, syringes, or other drug injection equipment — for example, cookers." Anything that touches blood can carry HIV and hepatitis C, so a new sterile set of everything for every injection is the goal.
Does an undetectable viral load prevent HIV transmission through shared needles?
U=U is established for sexual transmission. For shared injection equipment, the size of the risk reduction from an undetectable viral load has not been established, so it should not be relied on as protection when equipment is shared.
Are syringe exchange programs legal in Florida?
Yes. The Infectious Disease Elimination Act, signed June 27, 2019, allows county commissions statewide to authorize sterile needle and syringe exchange programs. Programs run on private funding, cannot collect identifying information, and operate on a one-to-one exchange basis. Miami's IDEA Exchange, which opened December 1, 2016, was Florida's first.
Related from RiseUpToHIV
References & Sources
- CDC — HIV Risk and Prevention Estimates. Per-act risk table (needle-sharing 63 per 10,000), the note that risks accumulate over time, and PrEP effectiveness of 74–84% among people who inject drugs. ↩ ↩ ↩ ↩ ↩
- Patel et al. — Estimating per-act HIV transmission risk: a systematic review. Source of the 63 per 10,000 needle-sharing estimate with its 95% CI of 41–92. ↩ ↩
- CDC — HIV and People Who Inject Drugs. Equipment sharing beyond syringes (cookers), 2018 diagnosis figures among PWID, and CDC's call to expand comprehensive syringe services programs. ↩ ↩ ↩ ↩
- CDC — Syringe Services Programs. Estimated 50% reduction in HIV and HCV infections, over two-thirds reduction combined with opioid use disorder medication, 5x/3x treatment-entry findings, safety and cost-saving evidence, and disposal plus naloxone services. ↩ ↩ ↩ ↩
- HIV.gov — Symptoms of HIV (HIV basics). Federal statement that PEP must be started within 3 days (72 hours) of a possible exposure. ↩
- CDC — What You Should Know About Xylazine. Xylazine combined with fentanyl, wound risks, unknowing exposure, and harm-reduction steps including sterile equipment and rotating injection sites. ↩ ↩
- Florida DOH — Infectious Disease Elimination Act (IDEA). June 27, 2019 signing, DOH's rationale for exchange programs, the ban on public funding, and the prohibition on collecting participants' identifying information. ↩ ↩ ↩
- Florida DOH — IDEA program requirements and reporting. County ordinance and DOH letter of agreement, eligible operators, the one-to-one exchange rule, required education, counseling, screening, naloxone, and August 1 annual reporting. ↩
- University of Miami Miller School of Medicine — IDEA Exchange. Opened December 1, 2016 on World AIDS Day as Florida's first legal syringe services program, and its full service list including HCV and HIV care, wound care, and peer navigation. ↩ ↩
- Florida DOH — State of the HIV Epidemic, 2023. 2023 Florida HIV diagnoses attributed to injection drug use and the care continuum for the 11,972 people living with HIV in Florida who inject drugs (62% suppressed vs. 70% statewide). ↩
Community publications like POZ, Positively Aware, and TheBody inform framing and lived-experience context on RiseUpToHIV. Every clinical, epidemiological, or public-health claim above is anchored to a primary source.